1. Ferlay, J. et al. GLOBOCAN 2012v1.0, Cancer incidence and mortality worldwide: IARC CancerBase. No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer. 11, http://globocan.iarc.f (2013).
2. Sherman, M. Hepatocellular carcinoma: Epidemiology, surveillance, and diagnosis. Seminars in Liver Disease 30, 3–16 (2010).
3. Nahon, P., Ganne-Carrié, N., Trinchet, J.-C. & Beaugrand, M. Hepatic iron overload and risk of hepatocellular carcinoma in cirrhosis. Gastroenterol. Clin. Biol. 34, 1–7 (2010).
4. Starley, B. Q., Calcagno, C. J. & Harrison, S. A. Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. Hepatology 51, 1820–1832 (2010).
5. Kinghorn, A. D., Chin, Y.-W. & Swanson, S. M. Discovery of natural product anticancer agents from biodiverse organisms. Curr. Opin. Drug Discov. Devel. 12, 189–196 (2009).